186 related articles for article (PubMed ID: 22037878)
1. Thrombospondin-1 triggers cell migration and development of advanced prostate tumors.
Firlej V; Mathieu JR; Gilbert C; Lemonnier L; Nakhlé J; Gallou-Kabani C; Guarmit B; Morin A; Prevarskaya N; Delongchamps NB; Cabon F
Cancer Res; 2011 Dec; 71(24):7649-58. PubMed ID: 22037878
[TBL] [Abstract][Full Text] [Related]
2. Androgens repress the expression of the angiogenesis inhibitor thrombospondin-1 in normal and neoplastic prostate.
Colombel M; Filleur S; Fournier P; Merle C; Guglielmi J; Courtin A; Degeorges A; Serre CM; Bouvier R; Clézardin P; Cabon F
Cancer Res; 2005 Jan; 65(1):300-8. PubMed ID: 15665307
[TBL] [Abstract][Full Text] [Related]
3. Transient potential receptor channel 4 controls thrombospondin-1 secretion and angiogenesis in renal cell carcinoma.
Veliceasa D; Ivanovic M; Hoepfner FT; Thumbikat P; Volpert OV; Smith ND
FEBS J; 2007 Dec; 274(24):6365-77. PubMed ID: 18021253
[TBL] [Abstract][Full Text] [Related]
4. Tasquinimod (ABR-215050), a quinoline-3-carboxamide anti-angiogenic agent, modulates the expression of thrombospondin-1 in human prostate tumors.
Olsson A; Björk A; Vallon-Christersson J; Isaacs JT; Leanderson T
Mol Cancer; 2010 May; 9():107. PubMed ID: 20470445
[TBL] [Abstract][Full Text] [Related]
5. Role of cationic channel TRPV2 in promoting prostate cancer migration and progression to androgen resistance.
Monet M; Lehen'kyi V; Gackiere F; Firlej V; Vandenberghe M; Roudbaraki M; Gkika D; Pourtier A; Bidaux G; Slomianny C; Delcourt P; Rassendren F; Bergerat JP; Ceraline J; Cabon F; Humez S; Prevarskaya N
Cancer Res; 2010 Feb; 70(3):1225-35. PubMed ID: 20103638
[TBL] [Abstract][Full Text] [Related]
6. Dysregulation of Rab37-Mediated Cross-talk between Cancer Cells and Endothelial Cells via Thrombospondin-1 Promotes Tumor Neovasculature and Metastasis.
Tzeng HT; Tsai CH; Yen YT; Cheng HC; Chen YC; Pu SW; Wang YS; Shan YS; Tseng YL; Su WC; Lai WW; Wu LW; Wang YC
Clin Cancer Res; 2017 May; 23(9):2335-2345. PubMed ID: 28151721
[No Abstract] [Full Text] [Related]
7. Tumor escape from endogenous, extracellular matrix-associated angiogenesis inhibitors by up-regulation of multiple proangiogenic factors.
Fernando NT; Koch M; Rothrock C; Gollogly LK; D'Amore PA; Ryeom S; Yoon SS
Clin Cancer Res; 2008 Mar; 14(5):1529-39. PubMed ID: 18316578
[TBL] [Abstract][Full Text] [Related]
8. SiRNA-mediated inhibition of vascular endothelial growth factor severely limits tumor resistance to antiangiogenic thrombospondin-1 and slows tumor vascularization and growth.
Filleur S; Courtin A; Ait-Si-Ali S; Guglielmi J; Merle C; Harel-Bellan A; Clézardin P; Cabon F
Cancer Res; 2003 Jul; 63(14):3919-22. PubMed ID: 12873985
[TBL] [Abstract][Full Text] [Related]
9. Quercetin inhibits angiogenesis through thrombospondin-1 upregulation to antagonize human prostate cancer PC-3 cell growth in vitro and in vivo.
Yang F; Jiang X; Song L; Wang H; Mei Z; Xu Z; Xing N
Oncol Rep; 2016 Mar; 35(3):1602-10. PubMed ID: 26676551
[TBL] [Abstract][Full Text] [Related]
10. ADAMTS1 alters blood vessel morphology and TSP1 levels in LNCaP and LNCaP-19 prostate tumors.
Gustavsson H; Tesan T; Jennbacken K; Kuno K; Damber JE; Welén K
BMC Cancer; 2010 Jun; 10():288. PubMed ID: 20546609
[TBL] [Abstract][Full Text] [Related]
11. Calcitriol reduces thrombospondin-1 and increases vascular endothelial growth factor in breast cancer cells: implications for tumor angiogenesis.
García-Quiroz J; Rivas-Suárez M; García-Becerra R; Barrera D; Martínez-Reza I; Ordaz-Rosado D; Santos-Martinez N; Villanueva O; Santos-Cuevas CL; Avila E; Gamboa-Domínguez A; Halhali A; Larrea F; Díaz L
J Steroid Biochem Mol Biol; 2014 Oct; 144 Pt A():215-22. PubMed ID: 24120914
[TBL] [Abstract][Full Text] [Related]
12. Beta-adrenergic signaling promotes tumor angiogenesis and prostate cancer progression through HDAC2-mediated suppression of thrombospondin-1.
Hulsurkar M; Li Z; Zhang Y; Li X; Zheng D; Li W
Oncogene; 2017 Mar; 36(11):1525-1536. PubMed ID: 27641328
[TBL] [Abstract][Full Text] [Related]
13. Suppression of thrombospondin-1 expression during uveal melanoma progression and its potential therapeutic utility.
Wang S; Neekhra A; Albert DM; Sorenson CM; Sheibani N
Arch Ophthalmol; 2012 Mar; 130(3):336-41. PubMed ID: 22411663
[TBL] [Abstract][Full Text] [Related]
14. Thrombospondin-1 suppresses tumorigenesis and angiogenesis in serum- and anchorage-independent NIH 3T3 cells.
Castle VP; Dixit VM; Polverini PJ
Lab Invest; 1997 Jul; 77(1):51-61. PubMed ID: 9251678
[TBL] [Abstract][Full Text] [Related]
15. In vivo mechanisms by which tumors producing thrombospondin 1 bypass its inhibitory effects.
Filleur S; Volpert OV; Degeorges A; Voland C; Reiher F; Clézardin P; Bouck N; Cabon F
Genes Dev; 2001 Jun; 15(11):1373-82. PubMed ID: 11390357
[TBL] [Abstract][Full Text] [Related]
16. Increased expression of EIF5A2, via hypoxia or gene amplification, contributes to metastasis and angiogenesis of esophageal squamous cell carcinoma.
Li Y; Fu L; Li JB; Qin Y; Zeng TT; Zhou J; Zeng ZL; Chen J; Cao TT; Ban X; Qian C; Cai Z; Xie D; Huang P; Guan XY
Gastroenterology; 2014 Jun; 146(7):1701-13.e9. PubMed ID: 24561231
[TBL] [Abstract][Full Text] [Related]
17. Vasoactive intestinal peptide enhances growth and angiogenesis of human experimental prostate cancer in a xenograft model.
Collado B; Carmena MJ; Clemente C; Prieto JC; Bajo AM
Peptides; 2007 Sep; 28(9):1896-901. PubMed ID: 17544169
[TBL] [Abstract][Full Text] [Related]
18. Variable inhibition of thrombospondin 1 against liver and lung metastases through differential activation of metalloproteinase ADAMTS1.
Lee YJ; Koch M; Karl D; Torres-Collado AX; Fernando NT; Rothrock C; Kuruppu D; Ryeom S; Iruela-Arispe ML; Yoon SS
Cancer Res; 2010 Feb; 70(3):948-56. PubMed ID: 20103648
[TBL] [Abstract][Full Text] [Related]
19. Peroxisome proliferator-activated receptor gamma ligands improve the antitumor efficacy of thrombospondin peptide ABT510.
Huang H; Campbell SC; Bedford DF; Nelius T; Veliceasa D; Shroff EH; Henkin J; Schneider A; Bouck N; Volpert OV
Mol Cancer Res; 2004 Oct; 2(10):541-50. PubMed ID: 15498928
[TBL] [Abstract][Full Text] [Related]
20. BMP4/Thrombospondin-1 loop paracrinically inhibits tumor angiogenesis and suppresses the growth of solid tumors.
Tsuchida R; Osawa T; Wang F; Nishii R; Das B; Tsuchida S; Muramatsu M; Takahashi T; Inoue T; Wada Y; Minami T; Yuasa Y; Shibuya M
Oncogene; 2014 Jul; 33(29):3803-11. PubMed ID: 24013228
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]